Canaccord Genuity Lowers PT and Estimates on Delcath Systems (DCTH) Following Recent Investor Meeting

June 4, 2012 8:43 AM EDT
Get Alerts DCTH Hot Sheet
Price: $16.73 -3.63%

Rating Summary:
    8 Buy, 2 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Delcath Systems (NASDAQ: DCTH) price target of $5.00 (from $8.00).

Analyst, Jason R. Mills, said, "Delcath hosted an investor meeting in advance of the ASCO conference in Chicago. A solid panel of experts from the US and Europe highlighted the meeting. These physicians provided an interesting perspective about how CHEMOSAT fits in the oncology armamentarium. We reduce our forward estimates and price target to reflect dilution related to the recent equity offering and previously announced delay of the NDA filing (midAugust-E)."

For an analyst ratings summary and ratings history on Delcath Systems click here. For more ratings news on Delcath Systems click here.

Shares of Delcath Systems closed at $1.44 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change